Is Healthcare Services Group (HCSG) Fully Valued As It Raises 2027 Guidance?

Healthcare Services Group (HCSG) has drawn fresh attention after management raised full year 2027 earnings guidance and lifted its revenue growth outlook from mid single digits to low double digits.

The guidance update landed on a stock that was already trending higher, with a 7 day share price return of 19.85% and a year to date share price gain of 45.82% pushing Healthcare Services Group to $25.30. Short term momentum has been strong, while the 1 year total shareholder return of 33.58% and 3 year total shareholder return of 172.34% point to a story that has been building over time as investors react to changing expectations for the business and its risks.

Scan other service and outsourcing stocks that could be at a similar inflection point using our curated list of 21 high quality undiscovered gems while Healthcare Services Group is in the spotlight.

After a 7 day jump and fresh guidance from Healthcare Services Group, the real tension now is simple: pay up after the run, or wait for the valuation work to suggest a better entry.

Most Popular Narrative: 6% Undervalued

The most widely followed valuation narrative for Healthcare Services Group pegs fair value at $27.00, a touch above the latest $25.30 close. That gap is small enough that the story now hinges on whether cash use, contracts and capital returns can justify any further rerating.

The main factor that has to go right is that Healthcare Services Group continues to convert improved contracts, collections, and the growing campus services business into consistent cash generation while managing legal and operational risks.

The campus services division, which surpassed US$100 million in revenue in 2025 yet remains under 10% of total sales, still has room to scale through cross selling and niche campus acquisitions, which could add an additional revenue and earnings stream on top of the core skilled nursing business.

See why 4 investors see Healthcare Services Group as 6% undervalued.

Result: Fair Value of $27.00 (UNDERVALUED)

Still, the story around Healthcare Services Group can change quickly if another large client runs into trouble or if legal and compliance issues flare up again.

Find out about the key risks to this Healthcare Services Group narrative.

Another View: Healthcare Services Group Through The Earnings Lens

The first fair value story for Healthcare Services Group leans on analyst earnings forecasts and a future P/E of 28.3x. A different lens uses today’s P/E of 16.3x, which screens cheaper than the US Commercial Services industry at 18.8x but richer than a fair ratio of 10.8x. That gap points to valuation risk if sentiment cools before cash flow and buybacks do more of the heavy lifting. Which version of “value” do you trust most when price has already moved hard in the short term?

For investors weighing that question, it can help to step through how the earnings multiple, industry comparison and fair ratio interact over time. Then test whether your own expectations for Healthcare Services Group line up with those numbers before leaning into the current P/E story. See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Thinking the Healthcare Services Group story looks promising but complicated. Move quickly to review both sides of the ledger and weigh the 2 key rewards and 2 important warning signs

Looking for more investment ideas beyond Healthcare Services Group?

Do not stop your research with Healthcare Services Group. Broaden your watchlist now and give yourself more options before the next wave of opportunities moves without you.

• Target stocks that pair value with quality by reviewing our curated 28 high quality undervalued stocks to see which businesses currently align with disciplined pricing.
• Strengthen your defensive side by checking the 30 resilient stocks with low risk scores, which includes companies that score well on resilience when conditions get tougher.
• Hunt for potential leaders before they hit the mainstream by scanning the 7 elite penny stocks with strong financials with stronger fundamentals.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com